Besides, berberine inhibits tumor antigen-mediated IL-6 and TGF-β expression as well as IL-10 proliferation but restores anti-tumor cytotoxicity of T cells in the tumor microenvironment (135). The gene discussed is TGFB1; the disease is neoplasm.